Analysis of the Variables Influencing Valproic Acid Concentration in the Serum and Cerebrospinal Fluid of Chinese Patients After Craniotomy

被引:5
|
作者
Li, Zhihong [1 ,2 ]
Gao, Weiqi [2 ]
Liu, Guifen [1 ]
Chen, Weihong [2 ]
机构
[1] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Affiliated Da Yi Hosp, Shanxi Da Yi Hosp, Dept Pharm, 99 Longcheng St, Taiyuan 030032, Peoples R China
关键词
valproic acid; cerebrospinal fluid; therapeutic drug monitoring; gender; CYP2C9; UGT1A6; BLOOD-BRAIN-BARRIER; ANTIEPILEPTIC DRUG-RESISTANCE; PLASMA-CONCENTRATIONS; MULTIDRUG-RESISTANCE; MONITORING DATA; ELDERLY-PEOPLE; P-GLYCOPROTEIN; STEADY-STATE; EPILEPSY; PHARMACOKINETICS;
D O I
10.1097/FTD.0000000000000424
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Valproic acid (VPA) has been widely used in Chinese patients after craniotomy. Many studies have focused on the influencing factors of VPA serum concentration, but conclusions are sometimes paradoxical. Furthermore, the concentration of VPA in the cerebrospinal fluid (CSF) has been rarely reported. In the present study, VPA CSF concentrations were measured, and the potential factors influencing serum concentration and CSF distribution of VPA were investigated. In addition, the functional relationship between serum and CSF concentration was explored. METHODS: Subjects were patients who underwent craniotomy and were administrated with VPA and had a lumbar puncture. Serum and CSF VPA concentrations were measured by use of the Abbott i1000 system. CYP2C9 (430 C>T, 1075 A>C, 1076 T>C, 1080 C>G), UGT1A6 (541 A>G, 552 A>C), UGT2B7 (211 G>T, 802 C>T), and ABCB1 (1236 C>T, 2677 G>T/A, 3435 C>T) genotypes were determined by direct sequencing. Information, such as age, gender, and height, was collected, and their effect on serum and CSF VPA concentrations was investigated by univariate analysis and multiple linear regression analysis. RESULTS: First, the concomitant use of carbapenems (beta' = -0.422) and UGT1A6 (552 AA -> AC) (beta' = -0.249) had a significant negative correlation with the weight-adjusted VPA serum concentration (C:W ratio), whereas CYP2C9 (1075 AA -> AC) (beta' = 0.186) and gender (female compared with male) (beta' = 0.322) showed a positive correlation with VPA serum C:W ratio. The coefficient of determination (R) was only 0.348. Second, the relationship between the serum concentration and the CSF square root of the concentration (R-2 = 0.705) had a better linear fit. Third, serum VPA concentration (beta' = 0.810), concomitant use of glycerol fructose (beta' = 0.160), and age (>= 65 compared with <65) (beta' = 0.118) showed a positive correlation (R-2 = 0.748) with the variability of square root of the concentration of the CSF. CONCLUSIONS: In Chinese patients, after craniotomy, female patients with 1 or more of CYP2C9 (1075 AC) and UGT1A6 (552 AA) genotypes required a lower VPA dosage compared with male patient. There was a better-fitted linear relationship between VPA serum and the square root of CSF concentrations. CSF VPA concentrations were relatively stable, with only age and the use of glycerol fructose having a small influence.
引用
收藏
页码:450 / 456
页数:7
相关论文
共 50 条
  • [21] A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients
    Hermida, J
    Tutor, JC
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 (04) : 489 - 493
  • [22] Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders
    Melegos, DN
    Freedman, MS
    Diamandis, EP
    PROSTAGLANDINS, 1997, 54 (01): : 463 - 474
  • [23] Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS)
    Janik, P.
    Kwiecinski, H.
    Niebroj-Dobosz, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 356 - 356
  • [24] Concentration of enkephalins in cerebrospinal fluid of patients after severe head injury
    Stachura, Z
    Kowalski, J
    Obuchowicz, E
    Huzarska, M
    Herman, ZS
    NEUROPEPTIDES, 1997, 31 (01) : 78 - 81
  • [25] Analysis of Cerebrospinal Fluid and Serum CEA Concentration in Non-neoplastic Diseases
    Shi, Qiang
    Tian, Chenglin
    Huang, Xusheng
    Pu, Chuanqiang
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2016, 46 (02): : 180 - 183
  • [26] Serum and cerebrospinal fluid uric acid levels in multiple sclerosis patients
    Zamani, Alireza
    Rezaei, Aliakbar
    Khaeir, Fatemeh
    Hooper, D. Craig
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2008, 110 (06) : 642 - 643
  • [27] Cerebrospinal fluid and serum uric acid levels in patients with multiple sclerosis
    Dujmovic, Irena
    Pekmezovic, Tatjana
    Obrenovic, Radmila
    Nikolic, Aleksandra
    Spasic, Mihailo
    Stojkovic, Marija Mostarica
    Drulovic, Jelena
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (07) : 848 - 853
  • [28] Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period
    Ma, Jiuhong
    Fan, Xiuzhao
    Cai, Xinfeng
    Ji, Hongming
    Li, Yuanping
    Guo, Jinlin
    NEUROLOGY AND THERAPY, 2023, 12 (01) : 197 - 209
  • [29] Effect of ANKK1 Polymorphisms on Serum Valproic Acid Concentration in Chinese Han Adult Patients in the Early Postoperative Period
    Jiuhong Ma
    Xiuzhao Fan
    Xinfeng Cai
    Hongming Ji
    Yuanping Li
    Jinlin Guo
    Neurology and Therapy, 2023, 12 : 197 - 209
  • [30] Plasma and cerebrospinal fluid pharmacokinetics of valproic acid after oral administration in non-human primates
    Stapleton, Stacie L.
    Thompson, Patrick A.
    Ou, Ching-Nan
    Berg, Stacey L.
    McGuffey, Leticia
    Gibson, Brian
    Blaney, Susan M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (04) : 647 - 652